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Abstract 1 
Study question: Can human embryonic stem cell-derived trophoblastic spheroids be used to 2 
study the early stages of implantation? 3 
 4 
Summary answer: We generated a novel human embryonic stem cell-derived trophoblastic 5 
spheroid model mimicking human blastocysts in the early stages of implantation. 6 
 7 
What is known already: Both human embryos and choriocarcinoma cell line derived 8 
spheroids can attach onto endometrial cells and are used as models to study the early stages of 9 
implantation. However, human embryos are limited and the use of cancer cell lines for 10 
spheroid generation remains sub-optimal for research.  11 
 12 
Study design, size, duration: Experimental induced differentiation of human embryonic 13 
stem cells into trophoblast and characterization of the trophoblast.  14 
 15 
Participants/materials, setting, methods: Trophoblastic spheroids (BAP-EB) were 16 
generated by inducing differentiation of a human embryonic stem cell line, VAL3 cells with 17 
bone morphogenic factor-4, A83-01 (a TGF-β inhibitor), and PD173074 (a FGF receptor-3 18 
inhibitor) after embryoid body formation. The expressions of trophoblastic markers and hCG 19 
levels were studied by real-time PCR and immunohistochemistry. BAP-EB attachment and 20 
invasion assays were performed on different cell lines and primary endometrial cells. 21 
 22 
Main results and the role of chance: After 48 h of induced differentiation, the BAP-EB 23 
resembled early implanting human embryos in terms of size and morphology. The spheroids 24 
derived from embryonic stem cells (VAL3), but not from several other cell lines studied, 25 
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possessed a blastocoel-like cavity. BAP-EB expressed several markers of trophectoderm of 1 
human blastocysts on Day 2 of induced differentiation. In the subsequent days of 2 
differentiation, the cells of the spheroids differentiated into trophoblast-like cells expressing 3 
trophoblastic markers, though at levels lower than that in the primary trophoblasts or in a 4 
choriocarcinoma cell line. On Day 3 of induced differentiation, BAP-EB selectively attached 5 
onto endometrial epithelial cells, but not other non-endometrial cell lines or an endometrial 6 
cell line that had lost its epithelial character. The attachment rates of BAP-EB was 7 
significantly higher on primary endometrial epithelial cells (EEC) taken from 7 days after 8 
hCG induction of ovulation (hCG+7 day) when compared to that from hCG+2 day. The 9 
spheroids also invaded through Ishikawa cells and the primary endometrial stromal cells in 10 
the coculture. 11 
 12 
Limitations, reasons for caution: The attachment rates of BAP-EB were compared between 13 
EEC obtained from day 2 and day 7 of the gonadotrophin stimulated cycle, but not the natural 14 
cycles. 15 
 16 
Wider implications of the findings: BAP-EB have the potential to be used as a test for 17 
predicting endometrial receptivity in IVF cycles and provide a novel approach to study early 18 
human implantation, trophoblastic cell differentiation and trophoblastic invasion into human 19 
endometrial cells. 20 
 21 
Study funding/competing interest(s): This study was supported in part by a General 22 
Research Fund (Grant number: 17111414) from the Research Grants Council of Hong Kong. 23 
The authors declare no conflicts of interest. 24 
 25 
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Introduction 1 
Assisted reproductive techniques offer infertile couples the chance to have their own 2 
baby, although the success rate remains low. Implantation failure is one of the main reasons 3 
for the low success rate (Cha, et al., 2012), as only about 25% of the transferred embryos 4 
successfully implant (Edwards, 2006, Ferraretti, et al., 2012). However, the exact mechanism 5 
of implantation failure is still poorly understood. A prerequisite for establishing a successful 6 
pregnancy is the synchronized dialogue between a competent blastocyst and the receptive 7 
endometrium. During implantation, the trophectoderm of the blastocyst attaches onto the 8 
endometrial epithelium and differentiates into the trophoblast (Potgens, et al., 2002). 9 
Although animal models have shed some light on the “black box” of implantation, the 10 
applicability of these findings to humans is questionable. Furthermore, in vivo research on 11 
implantation in humans is constrained by ethical issues. Some in vitro human models have 12 
been developed that use primary trophoblastic cells or choriocarcinoma cell lines induced to 13 
form cell clumps (spheroids), which can then be used as embryo surrogates for studying 14 
trophoblast attachment and invasion (reviewed in Weimar, et al., (2013)). Because the 15 
availability of early placental tissues for research is limited and isolated trophoblast cells 16 
rapidly cease to proliferate in culture (Bilban, et al., 2010), choriocarcinoma cells lines (e.g., 17 
JAr, JEG-3 and BeWo) have been used as alternatives (Hohn, et al., 2000). We have 18 
previously used JAr cell spheroids to demonstrate that Dickoff-1, olfactomedin, 19 
2,3,7,8-tetrachlorodibenzo-p-dioxin, and perfluorooctanoic acid could suppress the 20 
attachment of the spheroids onto Ishikawa or RL-95 cell lines (Kodithuwakku, et al., 2011, 21 
Liu, et al., 2010, Tsang, et al., 2012, Tsang, et al., 2013). However, choriocarcinoma cells are 22 
cancer cells and their manner of attachment may not fully represent the process during 23 
implantation. Besides, both primary trophoblastic cells and the choriocarcinoma cell lines are 24 
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committed (mature) trophoblastic cells, which are already at a later developmental stage than 1 
trophectoderm cells in implantation.  2 
One approach to obtain trophoblast lineages is to derive them from trophoblast stem cells 3 
from mouse blastocysts (Tanaka, et al., 1998), but this strategy cannot be established in 4 
humans. An alternative strategy is to differentiate human embryonic stem cells (hESCs) into 5 
early human trophoblastic cells using bone morphogenic protein 4 (BMP4), a member of the 6 
transforming growth factor-β (TGF-β) superfamily (Xu, et al., 2002). These derived cells 7 
secreted placental hormones, expressed several trophoblastic cell-related genes (Schulz, et al., 8 
2008, Wu, et al., 2008, Yu, et al., 2011, Zhang, et al., 2008), and formed multinucleated 9 
syncytium that expressed chorionic gonadotropin A and B (Das, et al., 2007, Schulz, et al., 10 
2008, Xu, et al., 2002). Amita and coworkers recently showed that the addition of inhibitors 11 
of ALK4/5/7 and of fibroblast growth factor-2 (FGF2) signaling pathways during the 12 
differentiation process significantly induced the formation of trophoblastic cells (Amita, et al., 13 
2013). 14 
In the present study, we used a modified trophoblast differentiation protocol to generate 15 
hESC-derived trophoblastic spheroids, which resembled early implanting human blastocysts 16 
in size and morphology with blastocoel-like cavities. The spheroids expressed several 17 
trophoblastic markers, secreted human chorionic gonadotropin (β-hCG) and selectively 18 
attached onto receptive Ishikawa and primary endometrial epithelial cells (EEC). The novel 19 
hESC-derived trophoblastic spheroids represent an in vitro model that can be used to study 20 
human embryo implantation and trophoblastic invasion on human endometrial cells.  21 
  22 
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Materials and Methods  1 
Cell Lines  2 
The human embryonic stem cell line, VAL3, was obtained from Spanish Stem Cell Bank, 3 
Spain (Valbuena, et al., 2006). VAL3 was cultured on plates coated with Matrigel (BD 4 
Bioscience, USA) in mTeSRTM1 medium (STEMCELL Technologies, Canada) (Ludwig, et al., 5 
2006). Human choriocarcinoma JEG-3 cells (ATCC, USA), endometrial adenocarcinoma 6 
Ishikawa cells (Sigma, USA), immortalized oviductal epithelial cells (OE-E6/E7) established 7 
in our laboratory (Lee, et al., 2001), and monkey kidney epithelial cells (Vero) (Lee, et al., 8 
2001) were maintained in Dulbecco’s Modified Eagle’s Medium/Nutrient Mixture F-12 Ham  9 
(DMEM/F12, Sigma) supplemented with 10% fetal bovine serum (FBS; Invitrogen, USA). 10 
Non-receptive endometrial epithelial AN3CA cells (Hohn, et al., 2000) were maintained in 11 
Minimum Essential Medium (MEM, Sigma) supplemented with 10% FBS. Cervical cancer 12 
HeLa cells were maintained in DMEM (Sigma) supplemented with 10% FBS.  13 
 14 
Differentiation to Trophoblastic Cells  15 
The VAL3 cells were differentiated to trophoblastic cells using trophoblastic 16 
differentiation medium according to a published protocol (Amita, et al., 2013). Briefly, VAL3 17 
cells were digested with dispase at a ratio of 1:12 and cultured in mTeSRTM1 medium for 24 h. 18 
The culture medium was replaced with mouse embryonic fibroblast conditioned medium 19 
(MEF-CM) supplemented with 4 ng/mL basic fibroblast growth factor (bFGF; Invitrogen). 20 
After culture for a further 24 h, the medium was replaced by BAP [MEF-CM supplemented 21 
with 10 ng/mL BMP4 (R&D Systems, USA), 1 μM of an ALK4/5/7 inhibitor (A83-01; 22 
Stemgent, USA), and 0.1 μM of an FGF2-signaling inhibitor (PD173074; Stemgent)] 23 
differentiation medium. The medium was changed daily during the 9 days of culture. VAL3 24 
cultured in bFGF containing MEF-CM was used as the non-differentiated control. For the 25 
Comment [CF1]: Please define the abbreviations 
DMEM and MEM 
Comment [CL2]: this is defined in line 20. 
Comment [CF3]: Please explain what the b means. 
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gene expression analysis, cells cultured in BAP for 3, 5, 7, and 9 days were collected after 1 
trypsin digestion. For the immunocytochemical analysis, cells on day 9 of differentiation were 2 
fixed. For the measurement of β-hCG secretion, conditioned media were collected on days 6 3 
and 9 of differentiation. For the cell invasion assay, BAP-treated VAL3 cells were seeded onto 4 
a BioCoat™ Matrigel™ Invasion Chamber with 8-μm pore size (Becton-Dickinson, USA) in 5 
BAP for 5 days. The invaded cells were stained with crystal violet. 6 
 7 
Generation of BAP-EBs 8 
To generate trophoblast spheroids, VAL3 cells were adapted to single-cell culture by 9 
multiple passages in mTeSRTM1 medium. For spheroid differentiation, VAL3 cells were 10 
digested using accutase into single cells and seeded at density of 2.4 x 105 cells per well in an 11 
AggreWellTM400 (STEMCELL Technologies) and cultured in mTeSRTM1 with 10 μM 12 
Y-27632. The AggreWell was centrifuged and cells were allowed to aggregate for 24 h to 13 
form embryoid bodies (EBs) of similar sizes. The EBs were transferred into ultra-low 14 
attachment 6-well plates (Corning, USA) and cultured in BAP for 4 days (BAP-EB-0h, 15 
BAP-EB-24h, BAP-EB-48h, BAP-EB-72h, and BAP-EB-96h) to form the VAL3-derived 16 
trophoblastic spheroids. AggreWell spheroids were also generated from JEG-3, OE-E6/E7, 17 
Vero, and HeLa cells using the same procedure except that cells were trypsinized and seeded 18 
at densities of 2.4 x 105 cells per well on the AggreWellTM400 in their culture media, 19 
respectively.  20 
 21 
Spheroid Attachment Assay 22 
Endometrial epithelial Ishikawa cells were first used to study the attachment potential of 23 
BAP-EBs. Quantification of attachment was measured using our published protocols 24 
(Kodithuwakku, et al., 2011, Liu, et al., 2010). After differentiation for 48, 72, or 96 h, 60 25 
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BAP-EBs were selected by size (100 to 200 μm) and evenly distributed on a confluent 1 
monolayer of Ishikawa cells under a dissection microscope. The BAP-EBs and the Ishikawa 2 
cells were cocultured for 1 and 3 h. Non-adherent spheroids were removed by centrifugation 3 
at 10 g for 10 mins. The attachment rate was calculated as the number of attached BAP-EBs 4 
out of the total number of seeded BAP-EBs expressed as a percentage. To confirm if the 5 
attachment was specific to epithelial cells from endometrium, the attachment rate of 6 
BAP-EB-72h was measured on OE-E6/E7, Vero, and HeLa cells. Non-receptive endometrial 7 
epithelial AN3CA cells (Hohn, et al., 2000) and 5 µM methotrexate (MTX, Sigma) 8 
(Kodithuwakku, et al., 2011) were used as negative controls. To further validate the usefulness 9 
of the BAP-EB as a model for embryo attachment, the attachment rate of BAP-EB-72h on 10 
primary endometrial epithelial cells (EEC) obtained from subfertile women for IVF treatment 11 
on day 2 (Day hCG+2 ) post-human chorionic gonadotrophin (hCG) injection was compared 12 
with those on hCG+7 day. 13 
 14 
Isolation of Primary Trophoblast and Endometrial Cells  15 
Placental villi samples were obtained from patients in their first trimester undergoing 16 
termination of pregnancy. Endometrial biopsies were obtained from infertile women attending 17 
the Assisted Reproduction Unit, Queen Mary Hospital, for IVF treatment. No participants had 18 
any significant uterine or ovarian abnormalities based on transvaginal ultrasonography. 19 
Primary trophoblast cells were isolated according to the previously described method 20 
(Male, et al., 2012) with some modifications. Briefly, placental villi were minced and digested 21 
with 0.25% w/v trypsin for 15 mins at 37 oC. The digested cells were successively filtered 22 
through 100-μm and 40-μm filters (BD Bioscience, USA). The cells were pooled using 23 
Ficoll-Paque PLUS (GE Healthcare, UK) and centrifuged at 710 g for 20 mins. Cells in the 24 
middle layer were collected and incubated for 20 mins in a plastic cell culture flask to remove 25 
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adherent leukocytes. Non-adherent cells were harvested for qPCR analysis. 1 
Endometrial biopsies were obtained from the fundal part of the endometrium using a 2 
pipelle endometrial sampler (Laboratoire CCD, France) 7 days after the luteinizing hormone 3 
surge (LH+7) during a natural cycle. Primary endometrial stromal cells were prepared 4 
according to the previously described method (Arnold, et al., 2001) with some modifications. 5 
Briefly, endometrial tissues were twice washed with DMEM/F12 supplemented with 1% 6 
bovine serum albumin (Sigma), 2% penicillin/streptomycin, and 1% L-glutamic acid (Gibco, 7 
USA). The endometrial tissues were minced and digested with 0.5 mg/mL typeⅠcollagenase 8 
(Invitrogen) and 0.15 mg/mL deoxyribonuclease (Worthington, USA). The digested mixture 9 
was successively filtered through 100-μm and 40-μm filters. The collected stromal cells were 10 
maintained in DMEM/F12 supplemented with 10% FBS, 2% penicillin/streptomycin, and 1% 11 
L-glutamic acid. The purity of the stromal cells was confirmed by the expression of vimentin 12 
but not cytokeratin 7 (CK7). 13 
To obtain the endometrial aspirates for isolation of epithelial cells from receptive and 14 
non-receptive endometrium, we recruited subfertile women during their IVF treatment. 15 
Endometrial biopsies were taken on Day hCG+2 or hCG+7 when the women did not have an 16 
embryo transfer due to failure of finding sperm in testicular biopsy, failure of husband in 17 
submitting a semen after oocyte retrieval, fertilization failure or unfavorable hormonal 18 
environment. Primary EEC were isolated as described above except that the stromal cells 19 
were further removed by seeding into culture flask and cultured at 37 oC for 40 min. The 20 
unattached epithelial cells were reseeded with phenol red free DMEM/F12 supplemented with 21 
10% FBS and their corresponding hormone levels (Day hCG+2: 300 pM E2 and 10 nM P4; 22 
Day hCG+7: 500 pM E2 and 50 nM P4). 23 
 24 
Ethical approval 25 
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Written informed consents were obtained from all subjects recruited for primary 1 
trophoblast and endometrial cells collections. The study protocol was approved by the 2 
Institutional Review Boards of the University of Hong Kong/Hospital Authority Hong Kong 3 
West Cluster (IRB number UW14-153). 4 
 5 
Invasion of BAP-EBs into Ishikawa Cells or Primary Stromal Cells 6 
Migration and invasion of BAP-EB-72h on endometrial cells during coculture was 7 
assessed. Ishikawa cells or primary stromal cells were incubated with CellTracker™ Red 8 
CMAC (Life Technology) before the coculture experiment. High-speed spinning disk, 9 
wide-field, time-lapse imaging at 30-minute intervals was performed for 64 h on a 10 
PerkinElmer system (PerkinElmer Life and Analytical Sciences, USA) located in our Core 11 
Facility.  12 
 13 
Real-Time Quantitative PCR and Immunocytochemistry 14 
To measure transcript expression of the differentiation markers, the differentiated BAP 15 
cells and their appropriate controls were subjected to total RNA extraction using the 16 
mirVana™ miRNA isolation Kit (Ambion, Life Technologies). RNA was reverse transcribed 17 
using TaqMan® Reverse Transcription Reagents (Applied Biosystems Inc., Life Technologies, 18 
USA) followed by real-time quantitative PCR (qPCR) using the TaqMan® Gene Expression 19 
Assay on an Applied Biosystems 7500 Real-Time PCR System (Applied Biosystems Inc., 20 
Life Technologies). Quantification of human OCT4, NANOG, caudal-related transcription 21 
factor (CDX2), eomesodermin (EOMES), E74-like factor 5 (ELF5), β-hCG, human leukocyte 22 
antigen-G (HLA-G), SYNCYTIN, CK7 and H19 mRNAs were normalized to endogenous 23 
18S ribosomal RNA (internal control) using the 2-∆∆CT method. The data were analyzed by 24 
the software provided by the manufacturer (Applied Biosystems). 25 
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For immunocytochemical analysis, adherent cells or BAP-EBs in suspension were fixed 1 
with 4% paraformaldehyde (Sigma) and washed in PBS with 0.05% Tween-20 (Sigma). After 2 
permeabilization with 0.1% Triton X-100 (Sigma), the cells were blocked and incubated 3 
overnight with primary antibodies to OCT4 (Santa Cruz Biotechnology, USA), CDX2 4 
(BioGenex, USA), β-hCG (Abcam, UK), HLA-G (Abcam), SYNCYTIN (Santa Cruz), CK7 5 
(Abcam), E-cadherin (Abcam), zonula occluden-1 (ZO-1; Santa Cruz), and vimentin (Dako, 6 
Denmark). Corresponding normal IgG was used as the negative controls. The cells were 7 
washed and incubated with fluorescent secondary antibodies followed by nuclear staining 8 
with Hoechst 33258 (Sigma). The fluorescent images were captured under a confocal 9 
microscope (LSM 700; Carl Zeiss, Germany). 10 
 11 
Immunoassay for β-hCG 12 
The concentration of β-hCG in the conditioned media from ~300 to 400 BAP-EBs and 13 
spheroids derived from the different cell lines was measured using a commercially available 14 
kit (Access® 2 Immunoassay System; Beckman Coulter, USA) using an immunoassay system 15 
(Beckman Coulter). 16 
 17 
Proliferation Assay 18 
The cell growth of BAP-treated VAL3 was measured using a CyQuant NF Cell 19 
Proliferation Assay (Invitrogen). Briefly, VAL3 cells were seeded at a density of 4000 cells 20 
per well on Matrigel-coated 96-well plates (Nunc, Denmark). After culture for 24 h in 21 
mTeSRTM1, the cells were treated with BAP for 0, 24, 48, 72, 96 and 120 h. VAL3 cultured in 22 
mTeSRTM1 was used as the control for each time point. On the day of the assay, cells were 23 
washed with PBS and incubated with the dye binding solution for 30 mins at 37 oC. The 24 
fluorescence intensities were then determined using an ELISA reader (Infinite F200; Tecan, 25 
13 
 
USA). 1 
 2 
Apoptosis Assays 3 
Cell apoptosis analysis was examined by EnzChekCaspase-3 Assay Kit (Molecular Probes, 4 
USA) according to the manufacturer’s instruction. Briefly, after mTeSR TM1 or BAP treated 5 
for 0, 24, 48, 72, 96 and 120 h, the cells were lysed with lysis buffer before the addition of 6 
caspase-3 substrate Z-DEVD-R110. The released fluorescence signal of R110 was detected by 7 
a fluorescent spectrophotometer (Tecan Infintie T200, Switzerland) at wavelength of 8 
496nm/520nm.  9 
 10 
Statistical Analysis 11 
Data were analyzed and plotted using SigmaPlot software (Jandel Scientific, USA). Data 12 
were analyzed by Chi-Square test, t-test, Rank Sum test, or One Way ANOVA as appropriate. 13 
A value of P < 0.05 for a difference between groups was considered to be statistically 14 
significant. 15 
 16 
  17 
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Results 1 
BAP Induced Differentiation of hESC to Trophoblast-Like Cells 2 
In order to confirm the trophoblastic differentiation potential of VAL3 cells, the cells 3 
were differentiated to trophoblastic cells using the published protocol. During the induced 4 
differentiation of VAL3 cells with BAP over 9 days, there was a marked decrease in the 5 
expression of the pluripotent marker, OCT4, in the first 2-3 days of treatment. The 6 
expressions of several trophoblastic markers, β-hCG, HLA-G, SYNCYTIN, CK7, and H19, 7 
were increased with various time course during culture. In addition, highly expressed markers 8 
in mouse trophoblast stem cells, such as CDX2, EOMES, and ELF5, were substantially 9 
upregulated (Fig. 1A).  10 
Immunocytochemical analysis confirmed the expression of CK7, HLA-G, and β-hCG 11 
proteins in 9-day BAP-treated cells but not in the bFGF-cultured cells. Consistently, OCT4 12 
immunoreactivity was undetectable upon BAP treatment (Fig. 1B). Treatment of VAL3 cells 13 
cultured on a Matrigel-coated invasion chamber with BAP induced the migration and invasion 14 
of cells through the pores of the membrane in the chamber (Fig. 1C). Significantly higher 15 
levels of β-hCG were detected in the conditioned media from the BAP-treated cells on days 6 16 
and 9 of the differentiation compared to the bFGF-cultured cells (Fig. 1D). During the 17 
undifferentiated growth of VAL3 in mTeSRTM1 medium, the number of proliferating cells 18 
progressively increased from 0 to 120 h of culture. Upon treatment with BAP, the number of 19 
proliferating cells initially decreased up to 72 h of differentiation but increased again after 96 20 
h and beyond (Fig. 1E). However, not much change was detected in their apoptosis rate (Fig. 21 
1F). 22 
 23 
Use of hESC-Derived Trophoblastic Spheroids for the Study of Implantation 24 
We generated trophoblastic spheroids using our modified approach by forming embryoid 25 
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bodies from VAL3 cells and inducing differentiation with BAP treatment. We then examined 1 
their viability as a model for the study of implantation. 2 
 3 
BAP-EBs Resembled Human Blastocyst in Size and Morphology  4 
Following accutase digestion of the cultured VAL3 cells to single cells, cells were 5 
seeded at a density of 2.4x105 cells per well in an AggreWellTM400. After 24 h, EBs were 6 
formed with sizes ranging from 70 to100 μm containing about 200 cells (Fig. 2A-i). They 7 
were transferred to ultra-low attachment plates and differentiated in MEF-CM supplemented 8 
with BAP for 24 to 96 h (Fig. 2A ii to v). Representative photomicrographs of EB 9 
differentiation are shown in Figure 2A. The BAP-EBs formed spheroids with similar sizes to 10 
that of human blastocysts and had blastocoel-like cavities. More than 80% of the spheroids 11 
possessed a cavity after 48 h of BAP treatment (Fig. 2A-iii), which was maintained in some of 12 
the BAP-EBs after 72 h of BAP treatment (Fig. 2A-iv).  13 
The β-hCG levels measured in the spent media showed BAP-EBs (~300 to 400 spheroids) 14 
produced undetectable or a very low amounts of β-hCG (< 0.5 IU/L) at 0, 24, and 48 h of 15 
BAP treatment, but levels started to rise from 72 h of BAP treatment to 4 ± 1.5 IU/L, 16 
reaching 279 ± 125 IU/L at 96 h (Fig. 2B). 17 
Spheroids formed with JEG-3 cells had similar diameters to that of BAP-EBs, but no 18 
cyst-like structures were observed after culture with media supplemented with BAP for 24 to 19 
72 h (Supplemental Fig. 1). To determine if BAP induced trophoblastic differentiation in only 20 
hESCs, we subjected HeLa, OE-E6/E7, and Vero cells to sequential AggreWell aggregation 21 
and BAP treatment. These three cell lines did not form any embryoid body-like structures 22 
after 24 h of AggreWell aggregation (Supplemental Fig. 1). The cell clumps (irregularly 23 
shaped clumps) were transferred onto low attachment plates and treated with BAP for 72 h. 24 
The HeLa cell clumps increased in size but were irregularly shaped, whereas the Vero cells 25 
16 
 
remained as small cell clumps with no cavity formation. Interestingly, cyst-like structures 1 
were observed in the OE-E6/E7 cells after 24 h of BAP treatment. In contrast to the BAP-EBs, 2 
β-hCG was not detected in the spent media of HeLa, OE-E6/E7, and Vero cells (data not 3 
shown).  4 
 5 
BAP-EBs Attached onto Endometrial Epithelial Cells in a Time-Dependent Manner  6 
Functional characterization of BAP-EB was performed using our established trophoblast 7 
spheroids-endometrial cells coculture assay. The attachment rates were assessed after 8 
coculture of BAP-EB-48h, BAP-EB-72h, and BAP-EB-96h with Ishikawa cells for 1 and 3 h. 9 
Only very few BAP-EB-48h spheroids were shown to be attached onto the Ishikawa cells 10 
even after 3 h of coculture, whereas ~40% of the BAP-EB-72h and BAP-EB-96h spheroids 11 
were shown to be moderately attached after 1 h of coculture increasing to ~90% after 3 h 12 
(Table I).  13 
 14 
BAP-EBs Attached onto Receptive Endometrial Cells 15 
To determine if BAP-EBs selectively attached onto endometrial epithelial cells, we 16 
investigated the attachment of BAP-EB-72h onto confluent layers of OE-E6/E7, Vero, and 17 
HeLa cells. Compared to the attachment rate of BAP-EB-72h on Ishikawa cells (38% at 1 h 18 
and 82% at 3 h), the attachment rates on OE-E6/E7, Vero, and HeLa cells were very low 19 
ranging from ~2% to 4% after 1 h and from ~5% to 11% after 3 h (Table II). Treatment with 5 20 
μM MTX, which induced differentiation of choriocarcinoma cells and reduced their binding 21 
to the endometrial cells, significantly suppressed the attachment rate of BAP-EB-72h onto 22 
Ishikawa cells (20% at 1 h and 58% at 3 h; P<0.001 Chi-Square Test). Very low attachment 23 
rates were also observed (1% at 1 h and 11% at 3 h, P<0.001 Chi-Square Test) for 24 
BAP-EB-72 h on endometrial epithelial AN3CA cells, which are known to be non-adherent to 25 
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several trophoblastic spheroids. On the other hand, there was no attachment when 1 
BAP-treated (for 72 h) OE-E6/E7 spheroids and Vero cell clumps (Supplemental Fig. 1) were 2 
cocultured with Ishikawa cells (data not shown).  3 
 4 
BAP-EBs Attached onto Primary EECs isolated from hCG+7 but not hCG+2 days 5 
Human embryos cannot adhere to the endometrium in most part of the menstrual cycle 6 
except in a 4-5 days window of implantation (Miravet-Valenciano, et al., 2015). To confirm 7 
the specificity of BAP-EB attachment onto receptive EECs, primary EECs from Days hCG+2 8 
and hCG+7 were used in coculture with BAP-EB-72h for 3 h. The median attachment rates of 9 
BAP-EB-72h onto the EECs from Day hCG+7 were 68.5% (ranges 25-77%, n=4). None of 10 
the BAP-EB-72h attached onto the EECs from Day hCG+2 (n=4). The difference between the 11 
two groups was statistically significant (p<0.05). The median attachment rates of the JEG3 12 
spheroids onto the same hCG+2 EEC samples (10%, range 0-35%) were also significantly 13 
lower than that on hCG+7 EEC cells (97.5%, 65-100%). The attachment rates of the JEG3 14 
spheroids were significantly higher than that of the BAP-EB-72h when they were cocultured 15 
with the same EEC cells (Table III). 16 
 17 
BAP-EBs Expressed Trophoblastic Markers 18 
We examined marker gene expressions in BAP-EBs after differentiation for 24 to 96 h 19 
and in JEG-3 spheroids and primary trophoblastic cells for comparison. Results from qPCR 20 
showed that the expression of pluripotent markers, NANOG and OCT4, drastically decreased 21 
in BAP-EBs over this period. Trophoblastic marker genes, β-hCG, HLA-G, SYNCYTIN, 22 
CK7, and H19, started to become highly expressed in the BAP-EBs at 48 h and increased 23 
exponentially at 72 and 96 h (Fig. 2C). Interestingly, genes related to mouse blastocyst 24 
formation (EOMES, CDX2, and ELF5) were induced, and EOMES peaked at 24 h, CDX2 25 
18 
 
peaked at 48 h, and ELF5 peaked at 72 h of BAP treatment, respectively, but dropping 1 
thereafter (Fig. 2C). No mRNA of the endoderm marker, SOX17, or the mesoderm marker, 2 
Brachyury T, were detected in the differentiated BAP-EBs at any time point (data not shown). 3 
JEG3 spheroids expressed lower levels of β-hCG, SYNCYTIN, CK7, and ELF5, but 4 
significantly higher levels of H19 and EOMES compared with BAP-EB-72h and primary 5 
trophoblastic cells (Fig. 2C). 6 
Immunocytochemistry confirmed the induced expressions of β-hCG, CDX2, HLA-G, 7 
CK7, and SYNCYTIN in BAP-EBs (Fig. 3A). No signal was found when their corresponding 8 
normal IgG was used (data not shown). HLA-G and SYNCYTIN immunoreactivities were 9 
restricted to the peripheral layer of the BAP-EB, whereas CDX2 was detected in the nucleus 10 
of cells throughout the BAP-EB. The OCT4 immunoreactivity was high in BAP-EB-0h and 11 
BAP-EB-48h, but was almost undetectable in the BAP-EB-72h and BAP-EB-96h. Given that 12 
blastocoel-like cavities were formed in EBs after BAP treatment, we studied the presence of 13 
cell adhesion molecules, ZO-1 and E-cadherin. ZO-1 was mainly localized in the peripheral 14 
cells of the BAP-EB, whereas E-cadherin was detected in the majority of the cells throughout 15 
the BAP-EB (Fig. 3A). The cyst-like structure of BAP-EB-48h was clearly seen in the 3-D 16 
confocal image reconstructed from 16 consecutive optical sections of spheroids 17 
immunostained for E-cadherin (Fig. 3B and Supplemental online Video 1). 18 
 19 
BAP-EB Outgrowth on Ishikawa and Primary Stromal Cells  20 
To study the behavior of BAP-EBs after attachment onto Ishikawa cells, the cocultured 21 
plate was further incubated for 24 h. We observed BAP-EB cell spreading at 1, 3, and 24 h 22 
post-attachment as shown by the representative images in Figure 4A. CK7-positive BAP-EB 23 
cells protruded from the BAP-EBs and formed outgrowths into the Ishikawa cell monolayer 24 
19 
 
(indicated by an arrow in Fig. 4B). Confocal Z-stack images of eight consecutive optical 1 
sections showed BAP-EB-72h had invaded into the labeled Ishikawa cells (Fig. 4C). 2 
To further demonstrate the invasiveness of the BAP-EB, we adopted the published in 3 
vitro models for stromal invasion and trophoblast spreading during human blastocyst 4 
implantation (Carver, et al., 2003, Grewal, et al., 2008). We studied the outgrowth of 5 
BAP-EB-72h cocultured with a primary endometrial stromal cell layer for 24 h (Fig. 5A) or 6 
48 h (Fig. 5B). Immunoreactivities of trophoblastic markers, E-cadherin and SYNCYTIN, 7 
were detected in the BAP-EB outgrowth. Vimentin, a stromal cell marker, was detected in the 8 
stromal cells, but vimentin was not present in the area where BAP-EB was attached (indicated 9 
by an asterisk in Fig. 5A), indicating the trophoblastic cells had invaded through the stromal 10 
cells. In some areas where BAP-EB was attached, staining showed vimentin appeared to be 11 
large and round in shape with filamentous actin projections (indicated by an arrow in Fig. 5A). 12 
Time-lapse imaging confirmed the continuous outgrowth and invasion of BAP-EB-72h into 13 
Ishikawa (Supplemental online Video 2) and primary stromal cells (Supplemental online 14 
Video 3).  15 
 16 
  17 
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Discussion 1 
We developed a protocol to induce differentiation of hESCs to blastocyst-like spheroids 2 
that expressed various trophoblastic markers and β-hCG, and which selectively attached to the 3 
Ishikawa cells and primary EEC. The fact that BAP-EB only attached to receptive (Day 4 
hCG+7) but not to pre-receptive (Day hCG+2) primary EEC further support its potential use 5 
as embryo surrogates for studying early human embryo implantation, such as the study of 6 
implantation failure. Implantation failure is one of the major reasons for the limited success of 7 
treatments for assisted reproduction, but research in this area is constrained by ethical issues. 8 
Use of spheroids generated by our method could potentially remove these ethical constraints.  9 
Our novel spheroid model has several advantages over the current in vitro models of human 10 
embryo implantation that use primary trophoblasts from abortus or choriocarcinoma cell lines. 11 
First, the hESC lines can be cultured long-term to give an unlimited supply of BAP-EBs. 12 
Second, the hESC-derived trophoblastic spheroids selectively attached to receptive 13 
endometrial cells and displayed more “physiological” behavior in vitro than choriocarcinoma 14 
cells, which were relatively non-selective in their attachment to various cell types.  15 
Our aim was to generate trophoblastic spheroids that could mimic human blastocysts in 16 
the early stages of implantation. The human blastocyst is a fluid-filled sphere with a diameter 17 
of about 150-200 μm. The spheroids treated with BAP for 48 h were similar in size to 18 
blastocysts and had a blastocoel-like cavity. The development of trophectodermal tight 19 
junctions is a prerequisite for the formation of a blastocoel in blastocysts (Sheth, et al., 1997). 20 
Consistently, BAP-EBs expressed ZO-1 on the periphery of the spheroids, which allowed 21 
fluid to accumulate in the blastocoel-like cavity. BAP-EBs also expressed E-cadherin, a 22 
glycoprotein critical in the establishment of adhesion junctions in the trophectoderm (Kan, et 23 
al., 2007). E-cadherin-null embryos failed to form a trophectodermal epithelium or a 24 
blastocyst cavity (Ohsugi, et al., 1997).  25 
21 
 
The cells of the BAP-EB-48h spheroids expressed markers similar to the trophectoderm 1 
of human blastocysts, such as OCT4 but not NANOG, and the levels of CDX2 trophectoderm 2 
marker and CK7 trophectoderm/trophoblast marker peaked in this experimental group 3 
(Niakan and Eggan, 2013). In humans and mice, the expression of OCT4 is detectable at the 4 
8-cell stage (Liu, et al., 2004, Niakan and Eggan, 2013), which persists in the trophectoderm 5 
of the early blastocyst and is eventually restricted to the inner cell mass (ICM) in 6 
mid-blastocysts (Niakan and Eggan, 2013). On the other hand, NANOG expression is 7 
restricted to the ICM prior to OCT4 in both species (Dietrich and Hiiragi, 2007, Niakan and 8 
Eggan, 2013). The expression of CDX2 in the trophectoderm differs between these two 9 
species. In humans, CDX2 is expressed only after blastocyst formation (Niakan and Eggan, 10 
2013), but in mice, it is expressed at the 16-cell stage and is eventually restricted to the 11 
trophectoderm (Strumpf, et al., 2005).  12 
The formation of a blastocoel-like cavity appears to be a property of the trophectoderm / 13 
early trophoblastic cell-containing spheroids. Spheroids derived from human trophoblastic 14 
cell lines, such as Sw.71 (Holmberg, et al., 2012), JEG-3, or JAr cell lines (Kodithuwakku, et 15 
al., 2011, Liu, et al., 2010, Tsang, et al., 2012, Tsang, et al., 2013), are in a mature trophoblast 16 
developmental state and are compacted. The inclusion of BAP in the medium did not induce 17 
the formation of a cavity in the JEG-3 cells or in the Vero and HeLa cell lines. Interestingly, 18 
the BAP-treated oviductal OE-E6/E7 spheroids possessed a cystic structure. A recent study 19 
demonstrated that ex-vivo culture of label-retaining cells in the mouse distal oviduct gave rise 20 
to undifferentiated spheroids (Wang, et al., 2012). This interesting feature of the OE-E6/E7 21 
cells warrants further investigation, but their lack of β-hCG secretion and the inability of their 22 
spheroids to attach onto endometrial cells suggest that they are not trophoblastic in nature.  23 
The process of differentiation in the BAP-EBs in vitro was dynamic over time. BAP-EBs 24 
were observed to be trophectoderm-like at 48 h, but they continued to differentiate and 25 
22 
 
expressed increasing amounts of the trophoblast lineage markers, SYNCYTIN and HLA-G, 1 
up to 96 h of BAP treatment. Other observations that showed the gradual differentiation of 2 
BAP-EB-48h to trophoblast-like cells included: (1) the exponential increase of β-hCG levels 3 
in the spent media after 48 to 96 h of induced differentiation; (2) increased expression levels 4 
of H19, which is associated with the differentiation of cytotrophoblast in vitro (Kliman, et al., 5 
1986); and (3) decreased expression of CDX2 to low levels after 48 h of induced 6 
differentiation. The latter two observations were in line with the supra-high levels of H19 7 
expression and the barely detectable CDX2 expression in JEG-3 spheroids and primary 8 
trophoblastic cells, indicating the differentiation of BAP-EBs toward trophoblast-like cells. 9 
Cdx2, Eomes, and Elf5 in mice are molecules in the early transcriptional network that 10 
control commitment of the trophectoderm and trophoblast stem cells. Elf5 is hypermethylated 11 
in the embryonic lineage but hypomethylated in the trophoblast lineage, and forms a positive 12 
feedback loop with Cdx2 and Eomes (Ng, et al., 2008). The expression of EOMES and ELF5 13 
in human blastocyst and early trophoblast is not fully understood. Whether the observed 14 
transient expressions of CDX2, EOMES, and ELF5 during differentiation of BAP-EBs 15 
recapitulate the development of the early human blastocyst and its differentiation into the 16 
trophoblast lineage will require further investigation. The expression patterns of these 17 
molecules in BAP-EBs were similar to those reported in BAP-induced differentiation of 18 
hESCs in two-dimensional cultures (Amita, et al., 2013). However, undetectable levels of 19 
ELF5 and EOMES, and inconsistent or no CDX2 expression were also found in other 20 
differentiation protocols (Harun, et al., 2006, Hemberger, et al., 2010, Udayashankar, et al., 21 
2011). Recently, it was shown that over-expression of CDX2 and EOMES could reprogram 22 
human fibroblasts into trophoblast progenitor cells (Aksoy, et al., 2013).  23 
Several groups have attempted to differentiate hESC into trophoblastic cells in 24 
two-dimensional cultures for the study of early placental development (Amita, et al., 2013, Li, 25 
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et al., 2013, Marchand, et al., 2011, Xu, et al., 2002). Comparative transcriptome analysis of 1 
the BMP-4 differentiated hESC and trophectoderm of human blastocysts showed that genes 2 
coding for implantation related secreted proteins were induced upon BMP-4 treatment 3 
(Aghajanova, et al., 2012). One study adopted an EB approach and produced extra villous 4 
trophoblast-like cells that exhibited high levels of hCG secretion (Udayashankar, et al., 2011). 5 
However, the study did not report the formation of spheroids with cavities, which could be 6 
due to their differentiation protocol or because they only studied hESC-derived trophoblasts 7 
after 5 days of EB differentiation, well beyond the trophectoderm-like stage. 8 
Although the formation of cystic spheroids was observed in the BAP-EB-48h, only the 9 
BAP-EB-72h spheroids were able to attach onto Ishikawa cells. The Ishikawa cells are 10 
commonly considered to be receptive endometrial epithelial cells because they have both 11 
glandular and luminal epithelial characteristics, express functional estrogen and progesterone 12 
receptor and well known molecules related to endometrial receptivity such as integrins and 13 
mucin, possess apical adhesiveness to trophoblast spheroids (Hannan, et al., 2010). The 14 
BAP-EB-72h spheroids selectively attached onto endometrial cells and did not significantly 15 
attach onto OE-E6/E7, HeLa, and Vero cells. Interestingly, the spheroids weakly attached onto 16 
endometrial epithelial AN3CA cells, which do not exhibit many of the epithelial cell-like 17 
characteristics (John, et al., 1993) and are non-adherent to commonly used trophoblastic 18 
spheroids (Hohn, et al., 2000). Treatment with MTX reduced the attachment of BAP-EBs 19 
onto Ishikawa cells, which was in agreement with previous reports that showed MTX induced 20 
differentiation of choriocarcinoma cells and reduced their binding to the endometrial cells 21 
(Hohn, et al., 2000). 22 
Most importantly, our newly established BAP-EB only attached onto primary EEC at the 23 
receptive phase (Day hCG+7) but not onto that at the pre-receptive phase (Day hCG+2). On 24 
the other hand, JEG3 attached fairly to 3 out of 4 Day hCG+2 samples of EEC samples. 25 
24 
 
Whether this observation is due to the invasive cancerous property of JEG3 required further 1 
investigation. Although the attachment rates of JEG3 spheroid were significantly higher than 2 
that of BAP-EB-72h when they were cocultured with the same EEC samples, similar 3 
differential binding of JEG3 spheroids onto hCG+2 and hCG+7 EEC were observed as for the 4 
BAP-EB-72h. Among the four EEC obtained from patients on Day hCG+7, differential 5 
attachment rates were noticed. Whether these differential rates can be used as a predictor to 6 
assess the receptivity of the endometrium and even the successful rates of human implantation 7 
during the IVF cycles requires further investigation. A large scale study on the correlation 8 
between the attachment rate of BAP-EB-72h onto primary EEC and pregnancy in IVF is 9 
ongoing.  10 
How BAP-EBs attached onto the endometrial cells is still not known. Initiation of 11 
implantation requires communication between the endometrium and the implanting blastocyst. 12 
The spheroids expressed E-cadherin, which is important for mouse embryo implantation (Liu, 13 
et al., 2006). In non-human primates, embryonic signals via chorionic gonadotropin induce 14 
changes in the endometrium required for successful implantation (Banerjee and Fazleabas, 15 
2010). In fact, hCG derived from the implanting embryos upregulated leukemia inhibitory 16 
factor, an endometrial receptivity marker, and enhanced endometrial epithelial cell receptivity 17 
(Sherwin, et al., 2007). It is possible the lack of attachment potential of BAP-EB-48h onto 18 
Ishikawa cells (within 3 h coculture) could be partly due to the insufficient production of 19 
β-hCG, which is required for the communication with endometrial cells. Indeed, most of the 20 
BAP-EB-48h were able to attach onto Ishikawa cells after 24 h of coculture (data not shown).  21 
After attachment, the trophoblast penetrates the uterine epithelium partly by inducing 22 
apoptosis of the adjacent epithelial cells (Galan, et al., 2000, Li, et al., 2003), and invades into 23 
the decidual cells of the stroma by secreting metalloproteinases that degrade the extracellular 24 
matrix (Cross, et al., 1994). An in vitro model of human embryo invasion was established by 25 
25 
 
directly cocultured human embryo with primary endometrial stromal cells using time-lapse 1 
imaging (Carver, et al., 2003, Grewal, et al., 2008).  A similar approach was adopted in our 2 
study to further demonstrate the invasion and spreading capability of BAP-EB. We observed 3 
that BAP-EBs possessed similar invasive capability as seen in the coculture with 4 
steroid-primed primary endometrial stromal cells. On day 1 after the coculture, the BAP-EBs 5 
had invaded through the underlying stromal cells as indicated by the lack of vimentin in the 6 
stromal cells in the area of the attached BAP-EBs. Furthermore, the BAP-EBs continued to 7 
grow out radially and formed SYNCYTIN-positive trophoblast-like cells. The further 8 
invasion of BAP-EBs was demonstrated by the gradual disappearance of labeled Ishikawa and 9 
stromal cells as seen in the 3-day time-lapse imaging.  10 
 11 
Summary 12 
We demonstrated our BAP-EB implantation model was reproducible and could be used 13 
as a valuable research tool for the study of human embryo implantation and trophoblast 14 
development. Understanding the process of implantation using a valid model is important for 15 
determining the cause(s) of implantation failure, and may eventually lead to methods to 16 
improve implantation. In addition, our method could potentially be used as a test for 17 
endometrial receptivity, which is currently lacking. 18 
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Figures Legends 1 
 2 
Figure 1. BAP induced trophoblast-like cells in VAL3.  3 
(A): Relative mRNA expressions of OCT4, β-hCG, HLA-G, CK7, H19, SYNCYTIN, CDX2, 4 
EOMES, and ELF5 after BAP treatment for 3, 5, 7, and 9 days. Data were normalized to 5 
VAL3 in a non-differentiated state (ES). Data were presented as mean ± SEM (n = 4). 6 
*P<0.05 compared with ES values (One-way ANOVA). (B): Immunocytochemical staining 7 
for CK7, HLA-G, β-hCG (red) and OCT4 (green) in 9-day bFGF- or BAP-treated cells. 8 
Nuclei were counterstained with Hoechst stain (blue). (C): Representative pictures (n=3) of 9 
BAP-treated cells invading through the pores of the membrane in the Matrigel-coated 10 
invasion chamber (stained with crystal violet). (D): β-hCG levels in the conditioned media on 11 
days 6 and 9 from BAP-treated cells. Data were presented as mean ± SEM (n = 3). *P<0.05 12 
compared with values from bFGF-treated cells. The cell proliferation (E) and apoptosis (F) 13 
curves during non-differentiated growth (mTeSRTM1, blue line) and BAP-induced 14 
differentiation (red line) of VAL3 from 24 to 120 h. Data were presented as mean ± SEM (n = 15 
3). 16 
 17 
Figure 2. VAL3-derived trophoblastic spheroids.  18 
(A): Representative pictures (n=4)of EBs after 24 h in AggreWell (i: 24h Aggrewell), and 19 
BAP-EB differentiation for 24 h (ii: BAP-EB-24h), 48 h (iii: BAP-EB-48h), 72 h (iv: 20 
BAP-EB-72h), and 96 h (v: BAP-EB-96h). Scale bar = 100 µm. Spheroids with 21 
blastocoel-like cavities are indicated by an arrow. (B): Levels of β-hCG in the spent media 22 
collected at 48, 72, and 96 h of BAP-EB differentiation. The levels (IU/L) were presented as 23 
mean ± SEM (n = 3). *P < 0.05 compared with values from BAP-EB-48h. (C): Relative 24 
mRNA expressions of NANOG, OCT4, β-hCG, HLA-G, SYNCYTIN, CK7, H19, CDX2, 25 
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EOMES, and ELF5 in BAP-EBs after differentiation for 0 (2), 24 (3), 48 (4), 72 (5), and 96 (6) 1 
h. JEG-3 spheroids (7) and primary trophoblastic cells (8) are shown for comparison. Data 2 
were normalized to VAL3 in non-differentiated state (ES) (1) and presented as mean ± SEM 3 
(n = 4). *P<0.05 compared with ES values. 4 
 5 
Figure 3. Immunocytochemical staining of trophoblastic markers in BAP-EB. 6 
(A): Representative pictures (n=3) of coimmunostaining for OCT4 (red) and β-hCG (green), 7 
CDX2 (red) and HLA-G (green), SYNCYTIN (red) and CK7 (green), ZO-1 (red) and 8 
E-cadherin (green) in BAP-EB-0h, BAP-EB-48h, BAP-EB-72h, and BAP-EB-96h. Nuclei 9 
were counterstained with Hoechst stain (blue). The blastocoel-like cavity in BAP-EB-48h is 10 
shown by the asterisk. n=3 (B): 3-D confocal images of 16 consecutive optical sections of 11 
BAP-EB-48h spheroids immunostainded for ZO-1(red) and E-cadherin (green). Nuclei were 12 
counterstained with Hoechst stain (blue). 13 
 14 
Figure 4. Attachment and outgrowth of BAP-EBs on Ishikawa cells.  15 
(A): Representative pictures (n=3) of the BAP-EB spheroids and Ishikawa cells cocultured for 16 
1, 3, and 24 h. Scale bar = 100μm. (B): Immunocytochemical staining for CK7 in 17 
BAP-EB-72h and Ishikawa cells after coculture for 24 h. Cells protruding from the clump and 18 
outgrowth into the monolayer are shown by the arrow. Phase contrast and confocal images 19 
(10x and 20x magnification). (C): Confocal Z-stack images of eight consecutive optical 20 
sections of BAP-EB-72h and labeled Ishikawa cells (red) after coculture for 64 h. Nuclei were 21 
counterstained with Hoechst stain (blue). 22 
 23 
Figure 5. Outgrowth of BAP-EBs onto primary endometrial stromal cells.  24 
(A): Outgrowth of BAP-EBs onto primary endometrial stromal cells after coculture for 24 h. 25 
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There was no vimentin immunoreactivity in the stromal cells underneath the attached 1 
BAP-EBs as indicated by an asterisk. Cells with actin filament-containing projections are 2 
shown by an arrow. (B): Detected immunoreactivities of trophoblastic markers (β-hCG, 3 
E-cadherin, SYNCYTIN, and vimentin) in the spreading cells of BAP-EB-72h after coculture 4 
with primary stromal cells for 48 h. Phase contrast and confocal images (10x and 20x 5 
magnification, representative pictures , n=3). 6 
 7 
Supplemental Figure 1. Morphology of spheroids derived from JEG3, OE-E6E7, Vero, 8 
and HeLa cells. 9 
Representative pictures of spheroids formed from JEG3, OE-E6E7, Vero, and HeLa cells (n = 10 
200) after 24 h of aggregation in AggreWell (24h-Aggrewell) and after BAP treatment in low 11 
attachment wells for 24 h (24h-BAP), 48 h (48h-BAP), and 72 h (72h-BAP). Scale bar = 12 
100μm. 13 
 14 
Supplemental online Video 1. 3-D Reconstruction of Cavity Containing BAP-EB-48h. 15 
The cyst-like structure of BAP-EB-48h in the reconstructed 3-D confocal images from 16 16 
consecutive optical sections of spheroids immunostained for E-cadherin (green) and nuclei 17 
stained with Hoechst stain (blue). 18 
 19 
Supplemental online Video 2. Time-Lapse Images of BAP-EB-72h Cocultured with 20 
Ishikawa Cells for 64 h. 21 
The time-lapse images at 30-minute intervals showed BAP-EB-72h invading into and 22 
spreading onto labeled Ishikawa cells (red).  23 
 24 
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Supplemental online Video 3. Time-Lapse Images of BAP-EB-72h Cocultured with 1 
Primary Stromal Cells for 64 h  2 
The time-lapse images at 30-minute intervals showed BAP-EB-72h invading into and 3 
spreading onto labeled primary stromal cells (red).  4 
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